Amwill Health Care
add_icon

Amwill Health Care

42.50
0.00
(0.00%)
Market Cap
85.00 Cr
PE Ratio
7.44
Volume
0.00
Day High - Low
- - -
52W High-Low
65.20 - 28.91
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
85.00 Cr
EPS
5.71
PE Ratio
7.44
PB Ratio
1.06
Book Value
40.28
EBITDA
15.90
Dividend Yield
1.18 %
Industry
Healthcare
Return on Equity
14.17
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
neutral
Amwill Health Care Ltd's Investment Committee approved a ₹2 crore fixed deposit with Vysya Co-operative Bank to support long-term growth, disclosed under SEBI Listing Regulations.
neutral
Amwill Health Care re-appoints Tarun Gandhi and Anand Gandhi as Managing Directors for five years from January 2027, pending shareholder approval.
neutral
Amwill Health Care Limited's board will meet on May 30, 2026, to consider audited financial results for FY26 and recommend a final dividend.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,990.50
#1 4,77,587.63
41.71
#1 61,673.90
12.69
#1 11,565
25.80
66.37
8,056.00
2,13,861.49
81.06
11,067.00
13.95
2,568
13.44
82.30
5,122.80
1,94,854.84
86.65
13,886.20
20.34
2,138
3.28
64.10
1,473.20
1,19,011.77
35.29
29,044.60
2.24
3,870
-39.18
61.43
1,126.80
1,13,382.45
21.72
27,657.90
17.64
5,026
7.82
53.10
2,415.00
1,10,421.66
#1 20.65
29,038.90
#1 26.75
5,356
87.72
49.50
2,469.60
1,01,993.49
51.48
14,636.40
14.85
1,938
29.13
44.89
1,816.20
98,048.75
88.28
6,867.80
22.01
890
#1 123.93
81.68
1,148.10
95,828.36
30.00
35,058.60
3.90
4,158
-69.10
28.48
1,580.20
90,921.21
26.12
33,384.70
3.21
3,376
1.99
57.35
Growth Rate
Revenue Growth
17.19 %
Net Income Growth
6.54 %
Cash Flow Change
43.88 %
ROE
-8.58 %
ROCE
10.92 %
EBITDA Margin (Avg.)
9.82 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
2026
TTM
Revenue
18
28
30
44
41
48
8
Expenses
19
24
26
27
29
33
6
EBITDA
-1
4
4
17
12
16
2
Operating Profit %
-6 %
13 %
14 %
38 %
29 %
29 %
6 %
Depreciation
0
0
0
0
1
1
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
-1
3
4
17
12
15
2
Tax
0
1
1
4
1
4
1
Net Profit
-1
3
3
13
11
11
2
EPS in ₹
-0.64
1.65
2.00
8.01
6.63
5.71
299.20

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
8
7
12
19
72
87
Fixed Assets
1
0
1
1
1
1
Current Assets
7
6
11
18
22
72
Capital Work in Progress
0
0
0
1
0
0
Investments
0
0
0
0
0
0
Other Assets
8
6
12
18
70
85
Total Equity & Liabilities
8
7
12
19
72
87
Current Liabilities
9
5
8
2
2
6
Non Current Liabilities
0
0
0
0
0
0
Total Equity
-1
2
5
17
69
81
Reserve & Surplus
-1
2
5
17
49
61
Share Capital
0
0
0
0
20
20

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
2026
Net Cash Flow
-1
3
3
-5
1
14
Investing Activities
-1
-0
-1
-1
-46
6
Operating Activities
0
3
5
-3
6
8
Financing Activities
0
0
-0
0
41
-0

Share Holding

% Holding
May 2024
Jan 2025
Feb 2025
Mar 2025
Sept 2025
Mar 2026
Promoter
97.00 %
97.00 %
97.00 %
70.65 %
70.65 %
70.65 %
FIIs
0.00 %
0.00 %
0.00 %
1.16 %
1.16 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
0.00 %
21.14 %
24.85 %
26.37 %
Others
3.00 %
3.00 %
3.00 %
7.05 %
3.34 %
2.98 %
No of Share Holders
7
7
7
1,374
1,606
1,483

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.5
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.18

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
14 Aug 2026 42.11 42.50
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 83.99 84.46
14 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
14 Aug 2025 67.06 63.00
04 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Nov 2025 50.70 54.00
30 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2026 32.38 32.70

Announcements

Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 201510 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26Jul 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 21, 2026
Disclosure Under Regulation 42 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Jul 17, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Of Board Of Directors Of Amwill Health Care Limited Held On July 172026.Jul 17, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2026
Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015Jun 19, 2026
SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO")May 30, 2026
Approval Of Audited Financial Results For Half Year & FY 2026.May 30, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 30, 2026
Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Meeting Of The Board Of Directors Held On May 30 2026.May 30, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
Board Meeting Intimation for Convening Meeting Of The Board Of Directors On Saturday May 30 2026 To Consider And Approve Audited Financial Results For Financial Year Ended March 31 2026 And Recommendation Of A Final Dividend If AnyMay 26, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Update On Prior Intimation Regarding Cyber Security Incident.Apr 07, 2026
Closure of Trading WindowMar 26, 2026
Intimation Of IT Security IncidentFeb 18, 2026
Announcement Under Regulation 30(LODR)_( Reappointment Of Internal Auditor FY 2025-26)Feb 09, 2026
Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015Jan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO")Nov 04, 2025
Unaudited Financial Results For The Half Year Ended September 30 2025.Nov 04, 2025
Board Meeting Outcome for Board Meeting Outcome For The Meeting Of The Board Of Directors Held On November 04 2025 Nov 04, 2025
Board Meeting Intimation for For Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26 Has Been Rescheduled And Will Now Be Held On Tuesday November 04 2025.Oct 30, 2025
Board Meeting Intimation for Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26.Oct 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2025
Reg. 34 (1) Annual Report.Jul 18, 2025
Notice Of 08Th Annual General Meeting And Annual Report For FY 2024-25Jul 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On July 08 2025Jul 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2025
SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO")May 29, 2025
Audited Financial Results For The Half Year And Year Ended March 31 2025.May 29, 2025
Board Meeting Outcome for Board Meeting Intimation To Consider And Approve The Half Year And Yearly Audited Financial Results Of The Company For The Period Ended March 31St 2025.May 29, 2025
Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For Half Yeraly And Yearly For The Period Ened March 31 2025 Of The Company.May 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
Appointment Of Mr. Syed Shahabuddin (Cop:11932) Practicing Company Secretary Peer Review Certificate No. 3387/2023 As The Secreterial Auditor Of The Company For Financial Year 2024-25.May 09, 2025
Announcement Under Regulation 30 (LODR)Apr 16, 2025
Announcement Under Regulation 30(LODR)_( Appointment Of Internal Auditor FY 2024-25)Apr 16, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Appointment of Company Secretary and Compliance OfficerApr 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 02, 2025

Technical Indicators

RSI(14)
Neutral
53.63
ATR(14)
Less Volatile
1.83
STOCH(9,6)
Neutral
37.29
STOCH RSI(14)
Neutral
62.80
MACD(12,26)
Bearish
-0.13
ADX(14)
Weak Trend
14.13
UO(9)
Bearish
43.85
ROC(12)
Uptrend And Accelerating
4.04
WillR(14)
Neutral
-44.29